Synthesis, Structural Elucidation, Spectral Studies and Antimicrobial Activity of Pyrano-Pyrazole Derivatives
Sandip Vyas1*, Ketan Parmar2, Bhavesh Patel2, Mukesh Chaudhari2, Nikita Umrigar2 and Kalpesh Goswami1
1Department of Chemistry, The HNSB. Ltd. Science College, Himatnagar, India.
2Department of Chemistry, Sir P. T. Sarvajanik College of Science, Surat, India.
Corresponding Author E-mail: vyasspraghav0763@gmail.com
DOI : http://dx.doi.org/10.13005/ojc/380432
Article Received on : 18 Feb 2022
Article Accepted on :
Article Published : 14 Jul 2022
Reviewed by: Dr. Hakan Arslan
Second Review by: Dr.Guna Shekar
Final Approval by: Dr. Tanay Pramanik
The emergence of multidrug-resistant pathogens have posed a major challenge to the treatment strategies for infectious diseases. In this study, a panel of eight novel pyrano-pyrazole heterocyclic moiety were prepared by multi-component one-pot reactions. In the first step Pyrano-pyrazole moiety prepared by single pot multicomponent condensation of Ethyl 3-oxobutanoate, pyridine-4-carbohydrazide, Propanedinitrile, and substituted benzaldehydes. In the second step above synthesized pyrano- pyrazole derivative react with different substituted phenyl amino-acetyl chloride derivative to give final compound. All the compounds were obtained in reasonable yields bearing their characteristic structure as inferred from the spectral analysis. All the synthesized compounds were screened for antimicrobial activity. Product B-1, B-5 and B-8 is found to have remarkable antibacterial activity. Products B-4 and B-7 are moderately active and compound B-5 and B-6 are found to have remarkable Antifungal activity.
KEYWORDS:Antimicrobial activity; Derivatives; Pyrazole; Synthesis; Spectral
Download this article as:Copy the following to cite this article: Vyas S. Parmar K, Patel B, Chaudhari M, Umrigar N, Goswami K. Synthesis, Structural Elucidation, Spectral Studies and Antimicrobial Activity of Pyrano-Pyrazole Derivatives. Orient J Chem 2022;38(4). |
Copy the following to cite this URL: Vyas S. Parmar K, Patel B, Chaudhari M, Umrigar N, Goswami K. Synthesis, Structural Elucidation, Spectral Studies and Antimicrobial Activity of Pyrano-Pyrazole Derivatives. Orient J Chem 2022;38(4). Available from: https://bit.ly/3ID34Nw |
Introduction
The Pyrano-pyrazole moiety is a fascinating template in the pharmaceutical industry, and it is responsible for the molecule’s vast range of biological activity. Compound containing pyrano -pyrazole moiety can act as antimicrobial1, analgesic2, vasodilator3, anticancer4, anti-inflammatory5, inhibitors of human Chkl kinase6, antifungicidal7 and also as biodegradable agrochemicals8. Different methods of one pot multicomponent reactions (MCRs) known for the preparation of pyrano [2,3-c] pyrazole structures, either in two-, three-, or four-component reactions. 9-14.
In this study, we aimed to synthesis the substituted pyrano-pyrazole derivatives having biological activity as anti-bacterial and anti-fungal activities.
Experimental Section
Materials
All the compounds were synthesized using a high purity grade chemical, reagents, and solvents purchased from S. D. Fine chem and Merck Chemical Co. Aluminum precoated sheets (Merck Kieselgel 60 GF254) were used for TLC, which was observed using an ultraviolet lamp (254 and 365 nm).
Instrumentation
M. P. observed by a Veergo M. P. Instrument sand uncorrected. 1H NMR spectral data was obtained through Bruker (300 MHz) spectrophotometer at Sophisticated Analytical Instrumentation Facility (SAIF), Punjab. Mass spectra recorded with Waters Micromass and Fourier Transform Infrared spectroscopy was measured on Shimadzu Spectrophotometer.
Procedure
PART-A: [6-Amino-4-(4-chloro-phenyl)-5-cyano-3-methyl-4H-pyrano[2,3-c]pyrazol-1-yl]-pyridin-4-yl-methanone
A mixture of P-chloro aldehyde (0.01M), pyridine-4-carbohydrazide(0.01M), Ethyl 3-oxobutanoate (0.01M), Propanedinitrile(0.01M) and Sodium benzoate (5 mol%) was stirred in absolute Ethanol (10 ml) for 5-10 minutes at room temperature. After getting the solid, the crude product was filtered using whatman filter paper. Pure product was obtained by recrystallizing the crude product from ethanol.
PART-B: (substituted phenyl amino)-acetyl chloride
4-nitro aniline (0.01M) was dissolved in glacial acetic (15ml) containing 15ml of saturated solution of Sodium acetate. If substance not dissolved completely, the mixture was then warmed at 60 to 70 °C in water bath and subsequently it was cooled in ice-bath with continuous stirring. To avoid vigorous reaction Chloro acetyl chloride (1ml) was added drop wise. The white product was separated out and filtered after 30 minutes. The yield was washed with cooled H2O and was purify by recrystallization from ethanol.
PART-C:N-[4-(4-Chloro-phenyl)-5-cyano-3-methyl-1-(pyridine-4-carbonyl)-1,4-dihydro-pyrano [2,3-c]pyrazol-6-yl]-2-(substituted phenylamino)-acetamide
A mixture of products from Part-A (0.04M) and Part-B (0.04M) was taken in 25ml of absolute alcohol and refluxed for 4 hours at 65 to 70 °C. TLC was used to monitor the reaction’s conclusion. The reaction mass was put into pieces of ice and filtered when it was finished. To get the pure yield, the product was purify with recrystallization from hot ethanol.
Scheme 1 |
Scheme 2 |
Table 1: Structure of all final synthesized compounds. |
Compound B1
Yield B1 got as solid (69%). Melting Point 125.6. Ft-IR spectra, v, cm-1 : 1426, 1623 (C=C str. Aromatic), 3034 (C-H Aromatic), 1684,1726 (Ar-C=O, C=O), 2242 (CN), 3379 (N-H), 1495(-CH2), 3034 (-CH3), 1523 (-NO2), 742 (-Cl).
PMR(300 MHz, DMSO) : 2.54 (s, 3H), 3.42(s, 2H), 4.21(s, 1H), 4.61(s, 1H), 7.39 to 8.44 (m, 13H), 8.51 (s, 1H). m/z=569.96, Anal. Calc. (%) for C28H20ClN7O5 C 59.00, H 3.54. N 17.20 Instrument Value C 58.99, H 3.51, N 17.19.
Compound B2
Yield B2 got as solid (66%). Melting Point 135.9. Ft-IR spectra, v, cm-1 : 1431, 1634 (C=C str. Aromatic), 3039 (C-H Aromatic), 1690,1728 (Ar-C=O, C=O), 2248 (CN), 3384 (N-H), 1499(-CH2), 3029 (-CH3), 1534 (-NO2), 748 (-Cl).
PMR (300 MHz, DMSO) : 2.35 (s, 3H), 3.63(s, 2H), 4.29 (s, 1H), 4.68(s, 1H), 7.44 to 8.99 (m, 13H), 8.45 (s, 1H). m/z=569.96, Anal. Calc. (%) for C28H20ClN7O5 C 59.00, H 3.92. N 17.27 Instrument Value C 58.99, H 3.90, N 17.26.
Compound B3
Yield B3 got as solid (66%). Melting Point139.8Ft-IR spectra, v, cm-1 : 1419, 1633 (C=C str. Aromatic), 3038 (C-H Aromatic), 1674,1729 (Ar-C=O, C=O), 2252 (CN), 3383 (N-H), 1479(-CH2), 3044 (-CH3), 785 (-Cl).
PMR(300 MHz, DMSO) : 2.59 (s, 3H), 3.48(s, 2H), 4.29(s, 1H), 4.73(s, 1H), 7.45 to 8.88 (m, 13H), 8.65 (s, 1H). m/z=559.40, Analytical Calculation (%) C28H22Cl2N6O3 C 60.12, H 3.60. N 15.02Instrument value C 60.10, H 3.58, N 14.99.
Compound B4
Yield B4 was got as solid (71%). Melting Point 143.8. Ft-IR spectra, v, cm-1 : 1418, 1638 (C=C str. Aromatic), 3053 (C-H Aromatic), 1699,1739 (Ar-C=O, C=O), 2263 (CN), 3364 (N-H), 1488(-CH2), 3039 (-CH3), 1530 (-NO2), 746 (-Cl).
PMR (300 MHz, DMSO) : 2.67 (s, 3H), 3.31 (s, 2H), 4.11(s, 1H), 4.55(s, 1H), 7.49 to 8.91 (m, 13H), 8.66 (s, 1H). m/z=569.96, Anal. Calc. (%) for C28H20ClN7O5 C 59.00, H 3.54. N 17.20 Found C 58.98, H 3.52, N 17.17.
Compound B5
Yield B5 was got as solid (63 %). Melting Point 110.5. Ft-IR spectra, v, cm-1 : 1446, 1635 (C=C str. Aromatic), 3039 (C-H Aromatic), 1689,1741 (Ar-C=O, C=O), 2235 (CN), 3366 (N-H), 1489(-CH2), 3039 (-CH3), 749 (-Cl). 1H NMR (300 MHz, DMSO) : 2.34 (s, 3H), 3.48(s, 2H), 4.23(s, 1H), 4.66(s, 1H), 7.35 to 8.49 (m, 13H), 8.55 (s, 1H). m/z=538.98, Analytical Calculation (%) for C29H23ClN6O3 C64.62, H 4.30. N 15.59.Instrument Value C 64.59, H 4.29, N 15.58.
Compound B6
Yield B6 was got as solid (70 %). Melting Point 125.7. Ft-IR spectra, v, cm-1 : 1429, 1625 (C=C str. Aromatic), 3033 (C-H Aromatic), 1682,1728 (Ar-C=O, C=O), 2245 (CN), 3381 (N-H), 1498(-CH2), 2968 (-CH3), 745 (-Cl).
PMR(300 MHz, DMSO) : 2.52 (s, 3H), 3.44(s, 2H), 4.23(s, 1H), 4.65(s, 1H), 7.40 to 8.43 (m, 13H), 8.49 (s, 1H). m/z=538.98, Analytical Calculation (%) for C29H23ClN6O3 C 64.62, H 4.30. N 15.59 Instrument Value C 64.60, H 4.28, N 15.56.
Compound B7
Yield, B7 was got as solid (64 %). Melting Point 113.2. Ft-IR spectrum, v, cm-1 : 1427, 1638 (C=C str. Aromatic), 3038 (C-H Aromatic), 1685,1729 (Ar-C=O, C=O), 2249 (CN), 3372 (N-H), 1499(-CH2), 2925 (-CH3), 745 (-Cl).
PMR(300 MHz, DMSO) : 2.58 (s, 3H), 3.45(s, 2H), 4.25(s, 1H), 4.66(s, 1H), 7.44 to 8.49 (m, 13H), 8.55 (s, 1H). m/z=538.98, Analytical Calculation (%) for C29H23ClN6O3 C 64.62, H 4.30. N 15.59 Instrument Value C 64.61, H 4.28, N 15.57.
Compound B8
Yield B8 got as solid (65 %). Melting Point 161.8. Ft-IR spectrav, cm-1 : 1427, 1622 (C=C str. Aromatic), 3033 (C-H Aromatic), 1685,1725 (Ar-C=O, C=O), 2244 (CN), 3384 (N-H), 1497(-CH2), 3038 (-CH3), 747 (-Cl).PMR (300 MHz, DMSO) : 2.59 (s, 3H), 3.46(s, 2H), 4.25(s, 1H), 4.66(s, 1H), 7.44 to 8.54 (m, 13H), 8.55 (s, 1H). m/z=524.96, Analytical Calculation (%) for C28H21ClN6O3 C 64.06, H 4.03. N 16.01 Instrument Value C 64.02, H 4.01, N 16.00.
Results and Discussion
First synthesis of [2,3-c]pyrazole type derivatives were prepared by Gein et al. via one-pot reaction manners15. In Present work, one-pot design of pyrano[2,3-c]pyrazole derivatives through MCR of Ethyl 3-oxobutanoate, pyridine-4-carbohydrazide, Propanedinitrile, and substituted benzaldehydes. Here, we performed antimicrobial study of synthesized pyrano[2,3-c]pyrazoleheterocyclic derivatives.
Antibacterial activity
Figure 1: Antibacterial activity. |
Table 2: Antibacterial activity of synthesized compounds.
Compound |
Gram + |
Gram – |
||
MTCC 96 |
MTCC 442 |
MTCC 433 |
MTCC 1688 |
|
S. Aureus |
S. Pyogenus |
E. Coli |
P. Aeruginosa |
|
B-1 |
100 |
62.5 |
125 |
125 |
B-2 |
250 |
500 |
250 |
200 |
B-3 |
250 |
250 |
250 |
250 |
B-4 |
125 |
200 |
125 |
100 |
B-5 |
62.5 |
200 |
50 |
100 |
B-6 |
125 |
250 |
250 |
500 |
B-7 |
250 |
100 |
100 |
125 |
B-8 |
50 |
100 |
62.5 |
25 |
Antibacterial activity shown that compound B-1 is good active against S.Pyogenus. B-5 is good active against S.Aures and E.coli and B-8 is good active against S. Aureus, E. Coli and very good activity on P. Aeruginosa.
Antifungal activity
Figure 2: Antifungal activity |
Table 3: Antifungal activity of synthesized compounds.
Compound |
Minimal Inhibition Concentration |
||
MTCC 227 |
MTCC 282 |
MTCC 1323 |
|
C. Albicans |
A. Niger |
A. Clavatus |
|
B-1 |
500 |
500 |
>1000 |
B-2 |
500 |
500 |
1000 |
B-3 |
500 |
500 |
500 |
B-4 |
200 |
250 |
250 |
B-5 |
250 |
500 |
100 |
B-6 |
100 |
100 |
500 |
B-7 |
200 |
500 |
500 |
B-8 |
500 |
250 |
250 |
Antifungal activity shown that Product B-4 and B-7 are moderately reactive against C.Albicans. Product B-6 is better reactive against C. Albicans, A. Niger and compound B-5 good active against A. Clavatus.
Acknowledgment
The authors would like to acknowledge The HNSB. Ltd. Science College, Himmatnagar and P. T. Sarvajanik Science College, Surat for providing lab. Facility.
Conflicts of Interest
The Authors declare that there are no conflict of interest regarding this research paper.
References
- Mistry, P.T.; Kamdar, N.R.; Haveliwala, D.D.; Patel, S. K. J. Heterocycl. Chem. 2012, 49 (2), 349–357
CrossRef - Kuo, S.C.; Huang, L.J.; Nakamura, H. J. Med. Chem. 1984, 27 (4), 539–544
CrossRef - Ahluwalia, V.K.; Dahiya, A.; Garg, V. Indian J. Chem.,Sect B, 1997,36 (1), 88–90
- Wang, J. L.; Liu, D.; Zheng, Z.J.; Shan, S.; Han, X.; Srinivasula, S.M.; Croce, C.M.; Alnemri, E.S.; Huang, Z. Proc. Natl. Acad. Sci. U.S.A.,2009, 97 (13), 7124–7129
- Mandha, S. R.; Siliveri, S.; Alla, M.; Bommena, V. R.; Bommineni, M.R.; Balasubramanian, S. Bioorg. Med. Chem. Lett., 2012, 22 (16), 5272–5278
CrossRef - Foloppe, N.; Fisher, L.M.; Howes, R.; Potter, A.; Robertson, A.G.S.; Surgenor, A.E. Bioorg. Med. Chem. 2006, 14(14), 4792–4802
CrossRef - Ramiz, M.M.M.; Hafiz, I.S.A.; Rahim, M.A.M.A.; Gaber, H.M. J. Chin. Chem. Soc.2012,59 (1), 72–80
- Kiyani, H.; Samimi, H.A.; Ghorbani, F.;Esmaieli, S.;Curr. Chem. Lett.2013,2 (4), 197–206
- Otto, S.; Engberts, J.B.F.N. Pure Appl. Chem. 2000, 72 (7), 1365– 1372
CrossRef - Shestopalov, A. M.; Emeliyanova, Y. M.; Shestopalov, A. A.; Rodinovskaya, L. A.; Niazimbetova, Z. I.; Evans, D.H. Tetrahedron, 2003, 59 (38), 7491–7496
CrossRef - Zonouz, A. M.; Eskandari, I.; Khavasi, H.R. Tetrahedron Lett., 2012, 53 (41), 5519–5522
CrossRef - Aslam, N.; White, J. M.; Zafar, A. M.; Abdul, M. J.; Ghafoor, N.; Sajid; Noreen, S; Khan, M.A. Arkivoc, 2018, part vi, 139-203
CrossRef - Khalid M.; Shireen M. Research Journal of Chemistry and Environment, 2019, 23(10). 139-156
- Ganta, R. K.; Kerru, N.; Maddila S.; Jonnalagadda, S. B. Molecules, 2021, 26, 3270
CrossRef - Gein, V.L.; Zamaraeva, T.M.; Kozulina, I.V. Russ. J. Org. Chem., 2014, 50 (5), 691–693
CrossRef
This work is licensed under a Creative Commons Attribution 4.0 International License.